PFE's dividend has reached the sky-high (for a biotech) ~6% mark. Are the dividend and recent share price decline enough to make PFE an attractive play? PFE is following a similar trajectory to GILD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback